Pyoderma gangrenosum complicating pacemaker implant

Europace

Volumn 8, Issue 12, 2006, Pages 1068-1069

  Cosío, Francisco G ^a   Herrada, Carlos González ^a   Monereo, Alfonso ^a   Pastor, Agustín ^a   Núñez, Ambrosio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Pacemaker implant complications; Pathergy on pacemaker; Pyoderma gangrenosum

Indexed keywords

CLOXACILLIN; PREDNISONE;

AGED; ANAMNESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BACTERIAL GROWTH; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DEVICE INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; NEPHROTIC SYNDROME; PACEMAKER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN BIOPSY; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

AGED; ANTI-INFLAMMATORY AGENTS; DIABETES COMPLICATIONS; FEMALE; HEART BLOCK; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION; PACEMAKER, ARTIFICIAL; PARAPROTEINEMIAS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; PYODERMA GANGRENOSUM;

EID: 33845406129     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul114     Document Type: Article

References (6)

1. Su WPD, Davis MDP, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004;43:790-800.
2. Mlika RB, Riahi I, Fenniche S, Mokni M, Dhaoui MR, Dess N et al. Pyoderma gangrenosum: A report of 21 cases. Intern J Dermatol 2002;41:65-8.
3. Crowson AN, Magro C, Mih JR. Pyoderma gangrenosum: A review. J Cutan Pathol 2003;30:97-107.
4. Lo TSN, Grif.th M, Heber ME. Pyoderma gangrenosum presented as a refractory wound infection following permanent pacemaker implantation. Heart 2002;87:414.
5. Kaur MR, Gach JE, Marshall H, Lewis HM. Recurrent postoperative pyoderma gangrenosum complicating pacemaker insertion. J Eur Acad Dermatol Venereol 2006;20:461-88.
6. Reichrath J, Bens G, Bonowitz A, Tilden W. Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005;53:273-83.